Ron Blankstein (@RonBlankstein) profile picture

Clinical Cardiologist & Researcher Preventive Cardiology and Cardiac Imaging Professor of Medicine and Radiology, Harvard Medical School

Boston, MA
Joined December 2015
Photo by Ron Blankstein (@RonBlankstein)Photo by Ron Blankstein (@RonBlankstein)Photo by Ron Blankstein (@RonBlankstein)Photo by Ron Blankstein (@RonBlankstein)Photo by Ron Blankstein (@RonBlankstein)Photo by Ron Blankstein (@RonBlankstein)Photo by Ron Blankstein (@RonBlankstein)Photo by Ron Blankstein (@RonBlankstein)Photo by Ron Blankstein (@RonBlankstein)Photo by Ron Blankstein (@RonBlankstein)
In med school, I founded the PowerPoint Academy and taught students/professors/professionals to give effective academic presentations. So yes, I feel conflicted about the boom of AI-generated slides at conferences. 8 tips so your AI slides don’t look like everyone else’s 🧵
3
11
66
21,333
ZEUS trial: Ziltivekimab 15 mg SC once-monthly yielded comparable 3-point MACE incidence rate vs. placebo (6.7 vs. 6.8 per 100 person-years) over a median on-treatment period of 33 months in high-risk patients with ASCVD and CKD, showing no significant clinical benefit. Download slides here: clinicaltrialresults.org/wp-…
1
16
38
3,685
Important announcement! scct.org/page/EICcall2026?_z…
7
18
982
Ron Blankstein retweeted
Cover Story | Inflammation as a Treatable Target: The Rise of Cardio-Immunology - American College of Cardiology acc.org/Latest-in-Cardiology… Inspiring story @UVACVRC
13
30
1,551
Ron Blankstein retweeted
Presented at #TCT2026: In a randomized trial, CCTA-guided PCI with structured preprocedural planning and intraprocedural guidance was noninferior to intravascular ultrasound–guided PCI with respect to target-vessel failure at 12 months. Full P4 trial results: nej.md/48jfVly @crfheart
4
86
18
247
36,316
P4 is out: CT-guided PCI was noninferior to IVUS-guided PCI for 12-mo TVF (4.1% vs 4.6%; n=1,105, 23 centers). Procedures were 17 min shorter with less contrast and radiation, and safety was similar. CT moves from gatekeeper to procedural tool. #TCT2026 @ColletCarlos
6
19
1,231
Ron Blankstein retweeted
What is HALT? How is it different from valve thrombosis or pannus? Confused by the terminology? Join us at #TCT2026 session in complex case theatre 2 as we decode the differences, explore key multimodality imaging insights, and discuss treatment strategies through exciting cases From imaging to management—let’s clear the confusion! 🫀
7
1
30
5,448
The present of advanced submillimetric imaging is PHOTON COUNTING CT. This is today not tomorrow, in 5 or 10 years. This is a new imaging modality. It's a new approach, a new semeiology, a new opportunity for better outcomes and more personalized care. And tomorrow PCCT will also provide molecular imaging.
2
1
5
544
.@WilliamZoghbi What an honor to host you @Lahey_Clinic for Cardiology and Medicine Grand Rounds! You are an inspiration! Thank you for so many educational and life lessons! @HMethodistCV
3
7
1
59
4,733
Ron Blankstein retweeted
In our new @masala_study analysis @JACCJournals, Lp(a) levels vary among disaggregated South Asian groups, but the association between Lp(a) levels and outcomes does not. @UCSDCardiology @UCSDCardFellows sciencedirect.com/science/ar…
3
22
1
79
5,388
Ron Blankstein retweeted
A prevention conundrum: - LDL-C lowering is prioritized after an ASCVD event because near-term absolute risk is high. - Yet relative benefit is greater before a first event and at younger ages. sciencedirect.com/science/ar… (Burger PM et al Atherosclerosis 2024) We need to keep moving toward improving high lifetime-risk identification before the disease declares itself.
2
20
2
68
5,747
Ron Blankstein retweeted
How can the new FFR-CT consensus recommendations translate into everyday clinical practice? Join SCCT/ @SCAI experts for practical guidance on patient selection, image acquisition and standardized reporting. Register: ow.ly/Hz7F50ZYcHX
1
7
479
Ron Blankstein retweeted
There's still time to join us for the SCCT Cardiovascular Disease Prevention Symposium kicking off today at 10:20am ET. Learn more: scct.org/page/PreventionSymp SCCT thanks @ElucidBio and @Heartflow for their support of this event.
3
1
6
1,479
Ron Blankstein retweeted
That slide is brilliant- Dikec standing in for CAC made me laugh out loud. Kudos to you and Ron. CTA in asymptomatic individuals is exactly the question we keep facing in clinic. Registered.
1
2
256
Ron Blankstein retweeted
Join us tomorrow online for a fantastic @FiRSTSCCT annual prevention symposium led by @RonBlankstein register here scct.org/page/PreventionSymp I am talking about role of CTA in asymptomatic individuals This slide summarizes the talk👇
6
10
52
2,913
Ron Blankstein retweeted
What does lifestyle-first prevention look like in 2027? Join the CVD Symposium for talks on integrating AI, wearables & emerging technologies into patient care, w/ practical guidance on exercise, sleep & nutrition for patients w/ coronary heart disease. ow.ly/UcK650ZV3Ec
1
7
1
14
852
Replying to @loridanielsmd
@loridanielsmd kicking off the #proCardioForum with a great overview of the new gen six troponin assay. @procardioforum @ambarish4786 @mvaduganathan @RonBlankstein @lamcardio @yadersandoval
2
7
521